Table 1.
Relationship between Clinical Characteristics and FGG Expression
| Characteristic | Number (%) | FGG expression | p value | |
|---|---|---|---|---|
|
| ||||
| Positive | Negative | |||
| Total | 405 | 104 (25.7%) | 301 (74.3%) | |
| Age, years | ||||
| < 50 | 241 (59.5%) | 59 (14.6%) | 182 (44.9%) | 0.563 |
| ≥ 50 | 164 (40.5%) | 45 (11.1%) | 119 (29.4%) | |
| Tumor size, cm | ||||
| ≤ 2 | 167 (41.2%) | 45 (11.1%) | 122 (30.1%) | 0.394 |
| 2-5 | 202 (49.9%) | 47 (11.6%) | 155 (38.3%) | |
| ≥ 5 | 36 (8.9%) | 12 (3.0%) | 24 (5.9%) | |
| Histological status | ||||
| I | 122 (30.1%) | 14 (3.5%) | 108 (26.7%) | < 0.001 |
| II | 184 (45.4%) | 37 (9.1%) | 147 (36.3%) | |
| III | 99 (24.4%) | 53 (13.1%) | 46 (11.4%) | |
| Lymph node status | ||||
| 0 | 229 (56.5%) | 28 (6.9%) | 201 (49.6%) | < 0.001 |
| 1-3 | 107 (26.4%) | 29 (7.2%) | 78 (19.3%) | |
| ≥ 4 | 69 (17.0%) | 47 (11.6%) | 22 (5.4%) | |
| ER | ||||
| Positive | 253 (62.5%) | 63 (15.6%) | 190 (46.9%) | 0.641 |
| Negative | 152 (37.5%) | 41 (10.1%) | 111 (27.4%) | |
| PR | ||||
| Positive | 311 (76.8%) | 52 (12.8%) | 159 (39.3%) | 0.650 |
| Negative | 194 (47.9%) | 52 (12.8%) | 142 (35.1%) | |
| HER2 | ||||
| Positive | 104 (25.7%) | 26 (6.4%) | 78 (19.3%) | 0.897 |
| Negative | 301 (74.3%) | 78 (19.3%) | 223 (55.1%) | |